2013
DOI: 10.1021/cb400088q
|View full text |Cite
|
Sign up to set email alerts
|

Selective Small Molecule Probes for the Hypoxia Inducible Factor (HIF) Prolyl Hydroxylases

Abstract: The hypoxia inducible factor (HIF) system is central to the signaling of low oxygen (hypoxia) in animals. The levels of HIF-α isoforms are regulated in an oxygen-dependent manner by the activity of the HIF prolyl-hydroxylases (PHD or EGLN enzymes), which are Fe(II) and 2-oxoglutarate (2OG) dependent oxygenases. Here, we describe biochemical, crystallographic, cellular profiling, and animal studies on PHD inhibitors including selectivity studies using a representative set of human 2OG oxygenases. We identify su… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

8
131
1

Year Published

2015
2015
2021
2021

Publication Types

Select...
10

Relationship

3
7

Authors

Journals

citations
Cited by 103 publications
(140 citation statements)
references
References 40 publications
8
131
1
Order By: Relevance
“…To study whether pharmacological inhibition of PHD2 copied key phenotypes of PHD2 haplodeficiency (more in particular, whether it impaired CAF activation by reducing TGF-b1 secretion by cancer cells), we used IOX2, a pharmacological prolyl-hydroxylase inhibitor with higher specificity for PHD2 (Chowdhury et al, 2013). Treatment of PyMT cancer cells with 50 mM IOX2 for 48 hr, a concentration that upregulated HIF1a and HIF2a levels ( Figure S7B), decreased TGF-b1 secretion ( Figure 7T).…”
Section: Possible Translational Implicationsmentioning
confidence: 99%
“…To study whether pharmacological inhibition of PHD2 copied key phenotypes of PHD2 haplodeficiency (more in particular, whether it impaired CAF activation by reducing TGF-b1 secretion by cancer cells), we used IOX2, a pharmacological prolyl-hydroxylase inhibitor with higher specificity for PHD2 (Chowdhury et al, 2013). Treatment of PyMT cancer cells with 50 mM IOX2 for 48 hr, a concentration that upregulated HIF1a and HIF2a levels ( Figure S7B), decreased TGF-b1 secretion ( Figure 7T).…”
Section: Possible Translational Implicationsmentioning
confidence: 99%
“…The heterodimer binds to specific DNA sequences and upregulates transcription of target genes (Semenza, 2013). Thus hypoxia is reflected by stabilisation of HIF α-subunits, which themselves can also be stabilised by chemical compounds such as dimethyloxalylglycine (DMOG) (Elvidge et al, 2006) and a glycine-linked dipeptidylquinolone derivative, IOX2 (Chowdhury et al, 2013). Both compounds block oxygen-dependent prolyl-hydroxylation, thus inhibiting degradation of HIF α-subunits and activating the HIF pathway.…”
Section: Introductionmentioning
confidence: 99%
“…PHDs utilize α-ketoglutarate as a cosubstrate and contain Fe(II) in their active site, and they are inhibited by α-ketoglutarate analogs or by rather unspecific iron chelators and metal ions (Scholz and Taylor 2013). IOX2 represents a synthetic cell-permeable hydroxylase inhibitor with pronounced selectivity for PHD-2 (Chowdhury et al 2013;Murray et al 2010;Tian et al 2011). In NHEK and NHDF, we showed that IOX2 efficiently blocks the constitutive HIF-1α degradation under normoxic conditions.…”
Section: Discussionmentioning
confidence: 90%